Ranbaxy Laboratories

From WikiMD's WELLNESSPEDIA

Ranbaxy Laboratories is an Indian multinational pharmaceutical company that was incorporated in 1961. It is a subsidiary of the Japanese pharmaceutical company Daiichi Sankyo, who acquired it in 2008. Ranbaxy Laboratories was once the largest pharmaceutical company in India.

History[edit]

Ranbaxy was established by Bhai Mohan Singh in 1961. The company was named after its two original investors, Ranjit Singh and Gurbax Singh. In 1998, Ranbaxy entered the United States, the world's largest pharmaceutical market. In 2008, Daiichi Sankyo, a Japanese pharmaceutical company, acquired a controlling share in Ranbaxy.

Products[edit]

Ranbaxy Laboratories produces a wide range of pharmaceutical products, including branded drugs, generic drugs, over-the-counter drugs, and active pharmaceutical ingredients. The company's product portfolio includes treatments for a variety of medical conditions, such as cardiovascular disease, respiratory disorders, and infectious diseases.

Controversies[edit]

Ranbaxy has been involved in several controversies, including allegations of drug adulteration and fraud. In 2013, the company pleaded guilty to charges of selling adulterated drugs in the United States and agreed to pay a $500 million fine.

See also[edit]

References[edit]


External links[edit]

Stub icon

This pharmacology-related article is a stub. You can help WikiMD by expanding the page.

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Ranbaxy_Laboratories&oldid=6416462"